參考文獻 |
Anderson, S. and Hauck, W. W. (1990). Consideration of individual bioequivalence. Journal of Pharmacokinetics and Biopharmaceutics 18, 259-273.
Berger, R. L. (1982). Multiparameter hypothesis testing and acceptance sampling. Technometrics 24, 295-300.
Berger, R. L. and Hsu, J. C. (1996). Bioequivalence trials, intersection-union tests and equivalence confidence sets. Statistical Science 11, 283-319.
Brown, L. D., Casella, G. and Huang, J. T. G. (1995). Optimal confidence sets, bioequivalence, and limaçon of Pascal. Journal of the American Statistical Association 90, 880-889.
Brown, L. D., Huang, J. T. G. and Munk, A. (1997). An unbiased test for the bioequivalence problem. The Annals of Statistics 6, 2345-2367.
Chow, C.-S. and Liu, J.-P. (2008). Design and analysis of bioavailability and bioequivalence studies. Marcel Dekker, New York.
Durrleman, S. and Simon, R. (1989). Flexible regression-models with cubic-splines. Statistics in Medicine 8, 551-561.
Efron, B. (1981). Nonparametric estimates of standard error : the jackknife, the bootstrap, and other methods. Biometrika 68, 589-599.
Efron, B. (1987). Better bootstrap confidence intervals. Journal of the American Statistical Association 82, 171-185.
Efron, B. and Tibshirani, R. (1986). Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Statistical Science 1, 54-75.
Food and Drug Administration (1992). Guidance on statistical procedures for bioequivalence studies using a standard two-treatment crossover design. Division of Bioequivalence, Rockville, MD.
Food and Drug Administration (2001). Guidance for industry: statistical approaches to establishing bioequivalence. Center for Drug Evaluation and Research, Rockville, MD.
Food and Drug Administration (2003). Guidance for industry: bioavailability and bioequivalence studies for orally administered drug product-general considerations. Center for Drug Evaluation and Research, Rockville, MD.
Hauck, W. W., Hyslop, T., Anderson, S., Bois, F. Y. and Tozer, T. N. (1995). Statistical and regulatory considerations for multiple measures in bioequivalence testing. Clinical Research and Regulatory Affairs 12, 249-265.
Hauck, W. W. and Anderson, S. (1992). Types of bioequivalence and related statistical considerations. International Journal of Clinical Pharmacology, Therapy and Toxicology 30, 181-187.
Hsu, J. C., Huang, J. T. G., Liu, H.-K. and Ruberg, S. J. (1994). Confidence intervals associated with tests for bioequivalence. Biometrika 81, 103-114.
Ihaka, R. and Gentleman, R. (1996). R: A language for data analysis and graphics. Journal of Computational and Graphical Statistics 5, 299-314.
Liao, J. Z. (2005). Comparing the concentration curves directly in a pharmacokinetics, bioavailability/bioequivalence study. Statistics in Medicine 24, 883-891.
Lindsey, J. K., Byrom, W. D., Wang, J., Jarvis, P. and Jones, B. (2000). Generalized nonlinear models for pharmacokinetic data. Biometrics 56, 30-36.
Liu, J.-P. and Chow, C.-S. (1992). On the assessment of variability in bioavailability/bioequivalence studies. Communications in Statistics-Theory Methods 21, 2591-2607.
MacEachern, S. N. and Müeller, P. (1998). Estimating mixtures of Dirichlet process models. Journal of Computational and Graphical Statistics 7, 223–338.
Massey, F. J., Jr. (1951). The Kolmogorov-Smirnov test of goodness of fit. Journal of the American Statistical Association 46, 68-78.
Munk, A. and Pflüger, R. (1999). 1-alpha equivalence rules for convex alternatives are alpha/2-level tests-with applications to the multivariate assessment of bioequivalence. Journal of the American Statistical Association 94, 1311-1319.
Rowland, M. and Tozer, T. N. (1994). Clinical pharmacokinetics, concepts and applications. Williams and Wilkins, Baltimore.
Salway, R. and Wakefield, J. (2007). Gamma generalized linear models for pharmacokinetic data. Biometrics 64, 620-626.
Schuirmann, D. L. (1981). On hypothesis testing to determine if the mean of a normal distribution in contained in a known interval. Biometrics 37, 617.
Stacy, E.W. (1962). A generalization of the gamma distribution. Annals of Mathematical Statistics 33, 1187-1192.
Stone, C. J. (1994). The use of polynomial splines and their tensor products in multivariate function estimation (with discussion). The Annals of Statistics 22, 118-184.
Wagner J. G. (1993). Pharmacokinetics for the Pharmaceutical Scientist. Technomic: Pennsylvania.
Wang, W., Hwang, J. T. G. and Dasgupta, A. (1999). Statistical tests for multivariate bioequivalence. Biometrika 86, 395-402.
Wellek, S. (1993). Basing the analysis of comparative bioavailability trials on an individualized statistical definition of equivalence. Biometrical journal 35, 47-55.
Westlake, W. J. (1972). Use of confidence intervals in analysis of comparative bioavailability trials. Journal of Pharmaceutics Sciences 61, 1340-1341.
Westlake, W. J. (1981). Response to T.B.L. Kirkwood: bioequivalence testing-a need to rethink. Biometrics 37, 589-594.
Westlake, W. J. (1988). Bioavailability and bioequivalence of pharmaceutical formulations. In Biopharmaceutical Statistics for Drug Development (Karl E. peace, ed.) 329-352. Dekker, New York.
Yafune, A. and Ishiguro, M. (1999a). Bootstrap approach for constructing confidence intervals for population pharmacokinetic parameters. I: A use of Bootstrap standard error. Statistics in Medicine 18, 581-599.
Yafune, A. and Ishiguro, M. (1999b). Bootstrap approach for constructing confidence intervals for population pharmacokinetic parameters. II: A Bootstrap modification of standard two-stage method for Phase I trial. Statistics in Medicine 18, 601-612.
Yafune, A. and Ishiguro, M. (2003). A simulation-based confidence band for drug concentrations in blood: an application to a clinical phase I trial. Statistics in Medicine 22, 3045-3053.
黃慧雯,「雙向交叉設計下生物相等性的多元檢定」,國立中央大學,碩士論文,民國98年。
|